Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.23 EUR | -.--% | +8.49% | -21.77% |
05-07 | Argent BioPharma Reports CFO Appointment | MT |
05-07 | Argent BioPharma shares begin trading on OTCQB Venture Market | AN |
Sales 2022 | 4.73M 3.15M 2.9M 247M | Sales 2023 | 3.39M 2.25M 2.08M 177M | Capitalization | 16.75M 11.14M 10.27M 875M |
---|---|---|---|---|---|
Net income 2022 | -20M -13.3M -12.26M -1.04B | Net income 2023 | -20M -13.3M -12.26M -1.04B | EV / Sales 2022 | 9.75 x |
Net Debt 2022 | 2.47M 1.64M 1.51M 129M | Net Debt 2023 | 9.51M 6.33M 5.83M 497M | EV / Sales 2023 | 7.75 x |
P/E ratio 2022 |
-2.02
x | P/E ratio 2023 |
-0.7
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 9.44% |
1 week | +8.49% | ||
1 month | -0.43% | ||
3 months | -0.86% | ||
6 months | -43.63% | ||
Current year | -21.77% |
Managers | Title | Age | Since |
---|---|---|---|
Roby Zomer
FOU | Founder | 44 | 20/10/05 |
Yifat Steuer
COO | Chief Operating Officer | 53 | 03/10/22 |
Nadya Lisovoder
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Roby Zomer
FOU | Founder | 44 | 20/10/05 |
Director/Board Member | - | 31/05/23 | |
Daniel Robinson
BRD | Director/Board Member | - | 11-30 |
Date | Price | Change |
---|---|---|
31/05/24 | 0.23 | -.--% |
30/05/24 | 0.23 | -.--% |
29/05/24 | 0.23 | -.--% |
28/05/24 | 0.23 | +8.49% |
27/05/24 | 0.212 | -.--% |
Real-time BOERSE MUENCHEN, May 31, 2024 at 08:44 pm
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+37.29% | 6.02B | |
-21.28% | 4.19B | |
+4.52% | 3.25B | |
-18.16% | 2.87B | |
-7.70% | 2.37B | |
+41.50% | 1.89B | |
-4.05% | 1.58B | |
-15.56% | 1.54B | |
-14.62% | 1.5B |
- Stock Market
- Equities
- RGT Stock
- H5O0 Stock